Novel use of alprazolam as a potential HIV-1 latency reversing agent

by W. Elbezanti, A. Lin, S. Luca, F. Maldarelli, Z. Klase
Published 2017-12-01

HIV viremia is the product of a small fraction of infected cells

by E. Anderson, J. Bell, M. Kearney, J. Coffin, F. Maldarelli
Published 2017-12-01

Population genetic approaches to estimating the size of the HIV reservoir

by J. Hattori, V. Boltz, W. Shao, M. Kearney, F. Maldarelli
Published 2015-12-01

1 Analysis of intra-patient, full length HIV gagsequences identifies regions of variability

by E. Anderson, M. Gouzoulis, A. Ganesan, C. Rehm, S. Jones, F. Maldarelli
Published 2016-07-01

Diverse proviral structure of HIV integrants in clonally expanded cells

by F.R. Simonetti, J. Spindler, X. Wu, F. Maldarelli, J.M. Coffin
Published 2015-12-01

Ultradeep analysis of pretherapy HIV predicts large and genetically complex reservoirs during antiretroviral therapy

by K. Huik, J. Hattori, V. Boltz, J. Rausch, W. Shao, M. Kearney, J. Coffin, F. Maldarelli
Published 2019-12-01

HIV proviruses with identical sequences arise from cell expansion and infection by a common ancestor virus

by S. Patro, A. Niyongabo, S. Guo, X. Wu, E. Boritz, S. Deeks, F. Maldarelli, S. Hughes, J. Coffin, M. Kearney
Published 2019-12-01

In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation

by C. Lange, N. Lindo, R. Little, T. Uldrick, S. Hill, J. Bell, K. Lurain, R. Ramaswami, R. Yarchoan, F. Maldarelli
Published 2019-12-01

Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues

by F. Maldarelli, M. Gozoulis, X. Wu, L. Perez, R. Gorelick, C. Lange, S. Hill, J. Virga, T. Uldrick, R. Yarchoan, S. Hughes
Published 2019-12-01

OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy

by G. Bozzi, S. Watters, F.R. Simonetti, E. Anderson, R. Gorelick, W. Shao, J. Bell, C. Rehm, R. Dewar, R. Yarchoan, T. Uldrick, F. Maldarelli
Published 2016-07-01

35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo

by S.A. Watters, M.N. Polizzotto, W. Shao, R. Gorelick, E.M. Anderson, I. Sereti, K. Aleman, L. Kouyoudjian, J.B. Zeldis, T. Uldrick, R. Yarchoan, F. Maldarelli
Published 2016-07-01

Uncovering mechanisms of HIV persistence in HIV controllers by HIV sequence analysis in CD4 T cell subsets

by E. Boritz, S. Darko, F. Simonetti, D. Wells, X. Wu, L. Swaszek, G. Wolf, R. Hoh, A. Vostal, A. Ober, M. Hughes, D. Bunis, S. Migueles, J. Casazza, R. Koup, M. Connors, S. Moir, J. Martin, F. Maldarelli, S. Hughes, S. Deeks, D. Douek
Published 2015-12-01

Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer

by T.S. Uldrick, M.A. ‘Mac’ Cheever, P.H. Gonçalves, S. Fling, K. Aleman, B. Emu, M.S. Ernstoff, R. Gorelick, J. Kaiser, H. E Kohrt, A. Lacroix, M. Lindsley, L. M Lundgren, K. Lurain, F. Maldarelli, C. Parsons, E. Sharon, A. Widell, R. Yarchoan
Published 2017-12-01

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples

by M. F. Kearney, K. Lee, R. K. Bagni, A. Wiegand, J. Spindler, F. Maldarelli, P. A. Pinto, W. M. Linehan, C. D. Vocke, K. A. Delviks-Frankenberry, R. W. deVere White, G. Q. Del Prete, J. W. Mellors, J. D. Lifson, V. N. KewalRamani, V. K. Pathak, J. M. Coffin, S. F. J. Le Grice
Published 2011-01-01